Search results
Showing 8071 to 8085 of 8904 results
September 2025: This medtech innovation briefing (MIB) has been withdrawn. This is because the evidence for the technology has changed since the MIB was published. NICE no longer produces or maintains MIBs on behalf of NHS England.
September 2025: This medtech innovation briefing (MIB) has been withdrawn. This is because the evidence for the technology has changed since the MIB was published. NICE no longer produces or maintains MIBs on behalf of NHS England.
UroShield for preventing catheter-associated urinary tract infections (MIB191)
This advice has been updated and replaced by NICE healthtech guidance 620.
This advice has been updated and replaced by NICE healthtech guidance 570.
DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)
This advice has been updated and replaced by NICE healthtech guidance 594.
Leukomed Sorbact for preventing surgical site infection (MIB197)
This advice has been updated and replaced by NICE healthtech guidance 567.
PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)
This medtech innovation briefing has been updated and replaced by NICE medtech innovation briefing 313.
This advice has been updated and replaced by NICE healthtech guidance 655.
This advice has been updated and replaced by NICE medical technologies guidance 51.
NICE has withdrawn the med tech innovation briefing (MIB) on Peezy Midstream for urine collection.
This advice has been updated and replaced by NICE healthtech guidance 574.
This advice has been updated and replaced by NICE healthtech guidance 605.
The V.A.C. Veraflo Therapy system for infected wounds (MIB189)
This advice has been updated and replaced by NICE healthtech guidance 566.
This advice has been updated and replaced by NICE healthtech guidance 624.
Health app: ChatHealth communication platform in school nursing services (MIB130)
The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.